Skip to main content

Catalyst Pharmaceuticals Inc. Common Stock (CPRX)

About The Company

CPRX Stock Market Logo

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing innovative therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

IPO Year Sector Industry
2006 Health Care Biotechnology: Pharmaceutical Preparations

Catalyst Pharmaceuticals Inc. (CPRX) Latest News

Company Contact & Address (CPRX)

Corporate Headquarters Phone Website
United States
+1 305 420-3200 Official CPRX Website

CPRX Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ CPRX

Jobs & Employment at Catalyst Pharmaceuticals Inc.

LinkedIn Company Page
Official Career & Employment Page Employment & Jobs at Catalyst Pharmaceuticals Inc. (CPRX)

Related & Similar Stock Symbols

PARAA Stock Market Price & News


Paramount Global Class A Common Stock

LFMDP Stock Market Price & News


LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred …

AVID Stock Market Price & News


Avid Technology Inc. Common Stock